Abstract
The p53 protein is a transcription factor that preserves the integrity of the genome. The TP53 gene has inactivating mutations in about 50% of all human cancers. Some missense mutations lead to decreased thermal stability in the p53 protein, its unfolding and aggregation under physiological conditions. A general understanding of the impact of point mutations on the stability and conformation of mutant p53 is essential for the design and development of small molecules that target specific p53 mutations. In this work, we determined the thermostability properties of some of the most common mutant forms of the p53 protein—p53(R273H), p53(R248Q), p53(R248W) and p53(Y220C)—that are often considered as attractive therapeutic targets. The results showed that these missense mutations lead to destabilization of the p53 protein and a decrease in its melting temperature.
Funder
Russian Science Foundation
Subject
Paleontology,Space and Planetary Science,General Biochemistry, Genetics and Molecular Biology,Ecology, Evolution, Behavior and Systematics
Reference33 articles.
1. Hassin, O., and Oren, M. (2022). Drugging P53 in Cancer: One Protein, Many Targets. Nat. Rev. Drug Discov., 1–18.
2. TP53: An Oncogene in Disguise;Soussi;Cell Death Differ.,2015
3. Targeting Mutant P53 for Efficient Cancer Therapy;Bykov;Nat. Rev. Cancer,2018
4. Crystal structure of a p53 tumor suppressor-DNA complex: Understanding tumorigenic mutations;Cho;Science,1994
5. The P53 Pathway: Origins, Inactivation in Cancer, and Emerging Therapeutic Approaches;Joerger;Annu. Rev. Biochem.,2016
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献